NEW YORK (GenomeWeb News) – Canadian researchers are using Thermo Fisher Scientific’s LTQ Orbitrap ion trap mass spectrometer in studies of protein interactions and their involvement in diseases.
Thermo Fisher said today that the Institut de Recherches Cliniques in Montreal is using the firm’s mass spectrometry technology in its efforts to develop a more complete understanding of the human proteome through the Human Proteotheque Initiative.
The HuPI initiative, which includes collaborators at various universities and research centers, aims to develop maps of the human proteome that will form an atlas that “should become a valuable resource for scientists in basic biological and biomedical research because enzymes and other proteins carry most of the biological functions required for cell growth and differentiation.”
These maps will eventually be made publicly available, the company said.